Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemorrhagic Disorders”

7,128 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 7,128 results

Testing effectiveness (Phase 2)WithdrawnNCT05170789
What this trial is testing

Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Tulane University School of Medicine
Large-scale testing (Phase 3)Study completedNCT01788020
What this trial is testing

Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
University of Ulm 202
Testing effectiveness (Phase 2)Ended earlyNCT01023880
What this trial is testing

Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy

Who this might be right for
Multiple Myeloma
Cephalon 62
Early research (Phase 1)Not Yet RecruitingNCT07113496
What this trial is testing

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Who this might be right for
Relapsed or Refractory B-cell Hematologic MalignanciesB-cell Acute Lymphoblastic Leukemia (B-ALL)Multiple Myeloma (MM)+3 more
The First Affiliated Hospital with Nanjing Medical University 27
Not applicableStudy completedNCT01446783
What this trial is testing

IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients

Who this might be right for
Ehlers-Danlos Syndrome, Classic
Bispebjerg Hospital 15
Large-scale testing (Phase 3)Study completedNCT00546780
What this trial is testing

Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 31
Post-approval studies (Phase 4)WithdrawnNCT02969746
What this trial is testing

Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants

Who this might be right for
Anticoagulants; Circulating, Hemorrhagic Disorder
University Hospital, Angers
Not applicableStudy completedNCT03161626
What this trial is testing

Registry Study of COAGADEX® Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major Surgery

Who this might be right for
Factor 10 Deficiency
Bio Products Laboratory 3
Not applicableStudy completedNCT03602755
What this trial is testing

The First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain

Who this might be right for
Multiple Myeloma
Celgene 706
Not applicableStudy completedNCT04190615
What this trial is testing

Determination of ClotPro Paediatric Reference Range Study

Who this might be right for
Clotting and Bleeding DisordersChild DevelopmentInfant Development+1 more
National Institute of Children's Diseases, Slovakia 322
Not applicableStudy completedNCT05916885
What this trial is testing

Effects of Short-intensity Modified Constraint-induced Movement Therapy on Hand Function in Stroke Patients.

Who this might be right for
Hemorrhagic StrokeIschemic StrokeRehabilitation
Riphah International University 38
Early research (Phase 1)UnknownNCT04861480
What this trial is testing

Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Chongqing Precision Biotech Co., Ltd 18
Testing effectiveness (Phase 2)Study completedNCT00004889
What this trial is testing

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 8
Large-scale testing (Phase 3)Study completedNCT01775618
What this trial is testing

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Who this might be right for
Hemophilia A
Bayer 73
Testing effectiveness (Phase 2)Ended earlyNCT02566603
What this trial is testing

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 15
Early research (Phase 1)Study completedNCT04142086
What this trial is testing

Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults

Who this might be right for
Yellow Fever (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 73
Not applicableWithdrawnNCT02663648
What this trial is testing

Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders

Who this might be right for
Myeloproliferative DisordersPolycythemia VeraEssential Thrombocythemia+2 more
Shandong University
Not applicableStudy completedNCT04999085
What this trial is testing

Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaDisability Physical+1 more
UNC Lineberger Comprehensive Cancer Center 16
Early research (Phase 1)Looking for participantsNCT05652335
What this trial is testing

JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Who this might be right for
Relapsed or Refractory Multiple MyelomaPreviously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC 180
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Load More Results